my opinion is that pfizer will not get even close to either target, and they need to get to both. I think our biggest concern should be what happens immediately afterwards. Hopefully a huge investor frenzy of new retail investors and institutions jumping on board the rap train and pumping up the share price. This should happen because of validation from Pfizer, but maybe also because the flow of announcements might start up again with increased frequency, especially if they have been artificially held back.
- Forums
- ASX - By Stock
- RAP
- Valuing ResApp Health
Valuing ResApp Health, page-247
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online